Cargando…

Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer

Purpose: Pancreatic ductal adenocarcinoma (PDAC) is a malignant disease with a poor prognosis. One prominent aspect of PDAC that contributes to its aggressive behavior is its altered cellular metabolism. The aim of this study was to characterize the oncogenic effects of ubiquinol-cytochrome c reduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qing, Li, Mengge, Gan, Yu, Jiang, Shuheng, Qiao, Jie, Zhang, Wei, Fan, Yingchao, Shen, Yuling, Song, Yanfang, Meng, Zihong, Yao, Ming, Gu, Jianren, Zhang, Zhigang, Tu, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019160/ https://www.ncbi.nlm.nih.gov/pubmed/32089737 http://dx.doi.org/10.7150/thno.38704

Ejemplares similares

Increased Expression of Mitochondrial UQCRC1 in Pancreatic Cancer Impairs Antitumor Immunity of Natural Killer Cells via Elevating Extracellular ATP
por: Cong, Hui, et al.
Publicado: (2022)

Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy
por: Lin, Chin-Hsien, et al.
Publicado: (2020)

Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production
por: Fan, Yingchao, et al.
Publicado: (2015)

Adiponectin Suppresses Human Pancreatic Cancer Growth through Attenuating the β-Catenin Signaling Pathway
por: Jiang, Jinghui, et al.
Publicado: (2019)

Cadherin 13 Inhibits Pancreatic Cancer Progression and Epithelial-mesenchymal Transition by Wnt/β-Catenin Signaling
por: Xu, Dengfei, et al.
Publicado: (2020)

Nutlin-3a Decreases Male Fertility via UQCRC2
por: Shukla, Kamla Kant, et al.
Publicado: (2013)

The miR-370/UQCRC2 axis facilitates tumorigenesis by regulating epithelial-mesenchymal transition in Gastric Cancer
por: Wang, Dan-wen, et al.
Publicado: (2020)

Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma
por: Ellinger, Jörg, et al.
Publicado: (2016)

UQCRC1 variants in early-onset and familial Parkinson's disease in a Taiwanese cohort
por: Liao, Ting-Wei, et al.
Publicado: (2022)

Enriched Environment Inhibits Mouse Pancreatic Cancer Growth and Down-regulates the Expression of Mitochondria-related Genes in Cancer Cells
por: Li, Guohua, et al.
Publicado: (2015)

AMPK protects against alcohol-induced liver injury through UQCRC2 to up-regulate mitophagy
por: Lu, Xinyi, et al.
Publicado: (2021)

The lack of association between ubiquinol‐cytochrome c reductase core protein I (UQCRC1) variants and Parkinson's disease in an eastern Chinese population
por: Lin, Zhi‐Hao, et al.
Publicado: (2020)

PCSK9 mediates the oxidative low-density lipoprotein-induced pyroptosis of vascular endothelial cells via the UQCRC1/ROS pathway
por: Zeng, Junfa, et al.
Publicado: (2021)

ABCA8-mediated efflux of taurocholic acid contributes to gemcitabine insensitivity in human pancreatic cancer via the S1PR2-ERK pathway
por: Yang, Chunmei, et al.
Publicado: (2021)

CCR9 in cancer: oncogenic role and therapeutic targeting
por: Tu, Zhenbo, et al.
Publicado: (2016)

Tryptophan Oxidation in the UQCRC1 Subunit of Mitochondrial Complex III (Ubiquinol-Cytochrome C Reductase) in a Mouse Model of Myodegeneration Causes Large Structural Changes in the Complex: A Molecular Dynamics Simulation Study
por: Unni, Sruthi, et al.
Publicado: (2019)

YAP in pancreatic cancer: oncogenic role and therapeutic strategy
por: Mao, Wenhao, et al.
Publicado: (2021)

Oncogenic K-ras Induces Mitochondrial OPA3 Expression to Promote Energy Metabolism in Pancreatic Cancer Cells
por: Meng, Ning, et al.
Publicado: (2019)

Kras as a key oncogene and therapeutic target in pancreatic cancer
por: Collins, Meredith A., et al.
Publicado: (2014)

Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer
por: Kamerkar, Sushrut, et al.
Publicado: (2017)

Mitochondrial-Associated Protein LRPPRC is Related With Poor Prognosis Potentially and Exerts as an Oncogene Via Maintaining Mitochondrial Function in Pancreatic Cancer
por: Wang, Li, et al.
Publicado: (2022)

Identification of FEZ2 as a potential oncogene in pancreatic ductal adenocarcinoma
por: Yang, Chaozhi, et al.
Publicado: (2022)

Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling
por: Li, Jun, et al.
Publicado: (2019)

Oncogenic drivers and mitochondrial dependency
por: Alvarez-Calderon, Francesca, et al.
Publicado: (2015)

Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)

RNA Sequencing of Osteosarcoma Gene Expression Profile Revealed that miR-214-3p Facilitates Osteosarcoma Cell Proliferation via Targeting Ubiquinol-Cytochrome c Reductase Core Protein 1 (UQCRC1)
por: Zhao, Xin, et al.
Publicado: (2019)

Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer
por: Oran, Amanda R., et al.
Publicado: (2016)

Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities
por: Bansod, Sapana, et al.
Publicado: (2021)

ZBTB7A functioned as an oncogene in colorectal cancer
por: Wang, Li, et al.
Publicado: (2020)

Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice
por: Collins, Meredith A., et al.
Publicado: (2012)

Identification of the novel Np17 oncogene in human leukemia
por: Wu, Bowen, et al.
Publicado: (2020)

TEAD4 as an Oncogene and a Mitochondrial Modulator
por: Hsu, Sheng-Chieh, et al.
Publicado: (2022)

Increased mitochondrial fission is critical for hypoxia-induced pancreatic beta cell death
por: Zhang, Da, et al.
Publicado: (2018)

Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase
por: Zeng, Li-Fan, et al.
Publicado: (2014)

The Interplay between Oncogenic Signaling Networks and Mitochondrial Dynamics
por: Nagdas, Sarbajeet, et al.
Publicado: (2017)

MT1X is an oncogene and indicates prognosis in ccRCC
por: Ding, Yanpeng, et al.
Publicado: (2022)

Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
por: Luo, Yongde, et al.
Publicado: (2021)

FOXK1 plays an oncogenic role in the progression of hilar cholangiocarcinoma
por: Feng, Yujie, et al.
Publicado: (2021)

RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer
por: Kang, R, et al.
Publicado: (2014)

Brain Imaging Study on the Pathogenesis of Depression & Therapeutic Effect of Selective Serotonin Reuptake Inhibitors
por: Meng, Qi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ebpdv1b93klf9ur7jdq9ca3go9